» Articles » PMID: 37510941

Optical Coherence Tomography: Focus on the Pathology of Macula in Scleritis Patients

Overview
Journal J Clin Med
Specialty General Medicine
Date 2023 Jul 29
PMID 37510941
Authors
Affiliations
Soon will be listed here.
Abstract

Methods: Twenty-four patients diagnosed with scleritis were selected for this study. All of the patients went through basic ophthalmological examinations, such as visual acuity testing (VA), intraocular pressure measurement (IOP), slit lamp examination, ophthalmoscopic examination, and OCT. OCT examinations were taken by SD-OCT Spectralis OCT system (Heidelberg Engineering, Heidelberg, Germany).

Results: Twenty-seven eyes of 24 patients (7 males and 17 females) were included in this study, who were diagnosed with scleritis. OCT examinations showed epiretinal membrane (ERM) in three patients (12%), cystoid macular edema (CME) (three cases, 12%), diffuse macular edema (DME) (one case, 4%), and serous retinal detachment (SRD) (one case, 4%).

Conclusions: OCT proved to be a valuable, non-invasive method for detecting macular pathology in patients with scleritis. Despite the best treatment regimen applied, macular involvement resulting in reduced visual acuity (VA) can develop, which we could detect with OCT since macular edema (ME) is the leading cause of decreased vision due to the damaged outer blood-retina barrier (BRB) in inflammation. OCT investigation is a highly important method for early detection of ocular complications in scleritis in order to prevent blindness.

References
1.
Iannetti L, Tortorella P, DAmbrosio E, Spena R, Zito R, Gharbiya M . Epiretinal membranes in patients with uveitis: morphological and functional analysis with spectral domain optical coherence tomography. Biomed Res Int. 2013; 2013:284821. PMC: 3835473. DOI: 10.1155/2013/284821. View

2.
Wakefield D, Di Girolamo N, Thurau S, Wildner G, McCluskey P . Scleritis: challenges in immunopathogenesis and treatment. Discov Med. 2013; 16(88):153-7. View

3.
Han I, Jaffe G . Evaluation of artifacts associated with macular spectral-domain optical coherence tomography. Ophthalmology. 2010; 117(6):1177-1189.e4. DOI: 10.1016/j.ophtha.2009.10.029. View

4.
Ingaralingam S, Rauz S, Murray P, Barry R . Effectiveness of pharmacological agents for the treatment of non-infectious scleritis: a systematic review protocol. Syst Rev. 2020; 9(1):54. PMC: 7068966. DOI: 10.1186/s13643-020-01314-9. View

5.
Watson P, Romano A . The impact of new methods of investigation and treatment on the understanding of the pathology of scleral inflammation. Eye (Lond). 2014; 28(8):915-30. PMC: 4135249. DOI: 10.1038/eye.2014.110. View